2020
DOI: 10.1016/j.otorri.2019.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…MF intranasal spray is endorsed as a treatment option before adenoidectomy as the evidence suggests this as an effective treatment in improving AH symptoms as well as reducing the adenoid size. Ghafar [50] conducted a study to evaluate the effect of MF intranasal spray in children and adolescents with AH. The authors noted significant improvements in nasal obstruction, rhinorrhoea, cough, and snoring in patients after 12 weeks treatment with MF intranasal spray (p < 0.001).…”
Section: Treatment Interventionsmentioning
confidence: 99%
“…MF intranasal spray is endorsed as a treatment option before adenoidectomy as the evidence suggests this as an effective treatment in improving AH symptoms as well as reducing the adenoid size. Ghafar [50] conducted a study to evaluate the effect of MF intranasal spray in children and adolescents with AH. The authors noted significant improvements in nasal obstruction, rhinorrhoea, cough, and snoring in patients after 12 weeks treatment with MF intranasal spray (p < 0.001).…”
Section: Treatment Interventionsmentioning
confidence: 99%
“…Mometasone furoate (MF) is a synthetic glucocorticoid that has a high-potency inhibitory effect on inflammatory reactions. It has been reported that MF is very effective in reducing symptoms in chronic rhinosinusitis, persistent asthma and adenoid hypertrophy [11] , [12] , [13] . Although MF has been proven to have the effect of inhibiting the growth of acute lymphoblastic leukemia (ALL 2 ) cells in childhood [14] , the role of MF in osteosarcoma cells is still unknown.…”
Section: Introductionmentioning
confidence: 99%